GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLF) » Definitions » Cyclically Adjusted PS Ratio

OPHLF (Ono Pharmaceutical Co) Cyclically Adjusted PS Ratio : 2.03 (As of May. 30, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Ono Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2025-05-30), Ono Pharmaceutical Co's current share price is $10.378. Ono Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $5.11. Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 2.03.

The historical rank and industry rank for Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

OPHLF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.07   Med: 6.47   Max: 10.51
Current: 2.11

During the past years, Ono Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 10.51. The lowest was 2.07. And the median was 6.47.

OPHLF's Cyclically Adjusted PS Ratio is ranked better than
50.14% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.115 vs OPHLF: 2.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ono Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2025 was $1.602. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.11 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ono Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Ono Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.93 6.58 5.08 3.87 2.19

Ono Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.87 3.34 2.80 2.30 2.19

Competitive Comparison of Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Ono Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10.378/5.11
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Ono Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.602/111.1000*111.1000
=1.602

Current CPI (Mar. 2025) = 111.1000.

Ono Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.544 98.400 0.614
201509 0.543 98.500 0.612
201512 0.653 98.100 0.740
201603 0.800 97.900 0.908
201606 1.052 98.100 1.191
201609 1.093 98.000 1.239
201612 1.157 98.400 1.306
201703 0.935 98.100 1.059
201706 1.041 98.500 1.174
201709 1.059 98.800 1.191
201712 1.363 99.400 1.523
201803 1.123 99.200 1.258
201806 1.259 99.200 1.410
201809 1.269 99.900 1.411
201812 1.366 99.700 1.522
201903 1.145 99.700 1.276
201906 1.335 99.800 1.486
201909 1.385 100.100 1.537
201912 1.401 100.500 1.549
202003 1.248 100.300 1.382
202006 1.395 99.900 1.551
202009 1.434 99.900 1.595
202012 1.630 99.300 1.824
202103 1.370 99.900 1.524
202106 1.589 99.500 1.774
202109 1.577 100.100 1.750
202112 1.718 100.100 1.907
202203 1.547 101.100 1.700
202206 1.631 101.800 1.780
202209 1.572 103.100 1.694
202212 1.857 104.100 1.982
202303 1.657 104.400 1.763
202306 1.739 105.200 1.837
202309 1.939 106.200 2.028
202312 1.915 106.800 1.992
202403 1.568 107.200 1.625
202406 1.586 108.200 1.629
202409 1.826 108.900 1.863
202412 1.857 110.700 1.864
202503 1.602 111.100 1.602

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ono Pharmaceutical Co  (OTCPK:OPHLF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Ono Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.